None
Quote | Deciphera Pharmaceuticals Inc. (NASDAQ:DCPH)
Last: | $25.59 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $25.59 |
High: | $0 |
Low: | $0 |
Volume: | 16 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Deciphera Pharmaceuticals Inc. (NASDAQ:DCPH)
2024-06-11 10:22:44 ET More on Deciphera Pharmaceuticals Diving Into Deciphera Pharmaceuticals Deciphera Pharmaceuticals ticks higher as HSR waiting period for ONO sale expires ONO to acquire Deciphera Pharmaceuticals in $2.4B deal Seeking Alpha’s Quan...
– MOTION Phase 3 Data Demonstrate Robust Efficacy, Clinically Meaningful Improvements in Quality-of-Life Measures, and Well-Tolerated Safety Profile, Positioning Vimseltinib as Potential New TGCT Treatment – – Company Expects to Submit a New Drug Application (NDA) in ...
Message Board Posts | Deciphera Pharmaceuticals Inc. (NASDAQ:DCPH)
Subject | By | Source | When |
---|---|---|---|
$DCPH and the shorts continue | ALERTS100%to10000%GAIN | investorshub | 05/01/2023 9:24:25 PM |
$DCPH The trading last trade up | ALERTS100%to10000%GAIN | investorshub | 04/28/2023 10:29:39 PM |
$DCPH Have a look at this | ok2buy | investorshub | 04/28/2023 6:15:08 PM |
Thoughts on where this is headed? | Arcglass | investorshub | 04/24/2023 4:59:07 AM |
best news of the day | ALERTS100%to10000%GAIN | investorshub | 04/12/2023 12:44:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Deciphera Pharmaceuticals Inc. Company Name:
DCPH Stock Symbol:
NASDAQ Market:
Deciphera Pharmaceuticals Inc. Website:
– MOTION Phase 3 Data Demonstrate Robust Efficacy, Clinically Meaningful Improvements in Quality-of-Life Measures, and Well-Tolerated Safety Profile, Positioning Vimseltinib as Potential New TGCT Treatment – – Company Expects to Submit a New Drug Application (NDA) in ...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...